143 related articles for article (PubMed ID: 10461479)
1. Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.
Huang QR; Danis V; Lassere M; Edmonds J; Manolios N
Rheumatology (Oxford); 1999 Jul; 38(7):645-51. PubMed ID: 10461479
[TBL] [Abstract][Full Text] [Related]
2. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
[TBL] [Abstract][Full Text] [Related]
4. APO1/F AS promoter polymorphism in systemic lupus erythematosus (SLE): significance in clinical expression of the disease.
Pradhan VD
J Assoc Physicians India; 2012 Sep; 60():34-7. PubMed ID: 23547411
[TBL] [Abstract][Full Text] [Related]
5. A Fas promoter polymorphism at position -670 in the enhancer region does not confer susceptibility to Felty's and large granular lymphocyte syndromes.
Coakley G; Manolios N; Loughran TP; Panayi GS; Lanchbury JS
Rheumatology (Oxford); 1999 Sep; 38(9):883-6. PubMed ID: 10515651
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.
Huang QR; Morris D; Manolios N
Mol Immunol; 1997 Jun; 34(8-9):577-82. PubMed ID: 9393960
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the -1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification.
Huang QR; Manolios N
Pathology; 2000 May; 32(2):126-30. PubMed ID: 10840834
[TBL] [Abstract][Full Text] [Related]
8. Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.
Lin YZ; Li RN; Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Autoimmunity; 2014 Feb; 47(1):23-6. PubMed ID: 24219225
[TBL] [Abstract][Full Text] [Related]
9. Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese.
Horiuchi T; Nishizaka H; Yasunaga S; Higuchi M; Tsukamoto H; Hayashi K; Nagasawa K
Rheumatology (Oxford); 1999 Jun; 38(6):516-20. PubMed ID: 10402071
[TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.
Kanemitsu S; Ihara K; Saifddin A; Otsuka T; Takeuchi T; Nagayama J; Kuwano M; Hara T
J Rheumatol; 2002 Jun; 29(6):1183-8. PubMed ID: 12064832
[TBL] [Abstract][Full Text] [Related]
11. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
[TBL] [Abstract][Full Text] [Related]
12. Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility.
do Canto LM; Farias TD; Medeiros MD; Coêlho CC; Sereia AF; de Carlos Back LK; de Mello FM; Zimmermann AF; Pereira IA; de Souza IR
Rev Bras Reumatol Engl Ed; 2016; 56(6):483-489. PubMed ID: 27914594
[TBL] [Abstract][Full Text] [Related]
13. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
[TBL] [Abstract][Full Text] [Related]
14. Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis.
AlFadhli S; Ghanem AA
Immunol Invest; 2014; 43(5):411-23. PubMed ID: 24564745
[TBL] [Abstract][Full Text] [Related]
15. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
[TBL] [Abstract][Full Text] [Related]
16. PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients: any link with clinical atherosclerotic events?
Pamuk ON; Tozkir H; Uyanik MS; Gurkan H; Saritas F; Duymaz J; Donmez S; Yazar M; Pamuk GE
Clin Rheumatol; 2014 Dec; 33(12):1737-43. PubMed ID: 25201689
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis.
Lee YH; Kim HJ; Rho YH; Choi SJ; Ji JD; Song GG
Rheumatol Int; 2004 May; 24(3):133-6. PubMed ID: 14872281
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility.
Fu L; Jin L; Yan L; Shi J; Wang H; Zhou B; Wu X
Hum Immunol; 2016 Jan; 77(1):1-6. PubMed ID: 25218914
[TBL] [Abstract][Full Text] [Related]
19. Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Z Rheumatol; 2017 Oct; 76(8):708-715. PubMed ID: 27447696
[TBL] [Abstract][Full Text] [Related]
20. Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.
Moudi B; Salimi S; Farajian Mashhadi F; Sandoughi M; Zakeri Z
ScientificWorldJournal; 2013; 2013():176741. PubMed ID: 24348139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
